Thus English et al. [19] found that response to treatment of uterine serous carcinoma cell lines, especially cells over-expressing HER2, with 1 μM or 5 μM AZD8055 was associated with G0/G1 cell cycle arrest in a concentration-dependent manner. Here, ERBB2 is linked to endometrial serous adenocarcinoma.